New pill tested to slow scarring in lungs
Disease control
Completed
This study tested whether a daily oral pill called GRI-0621 is safe and can affect markers of disease in people with IPF, a condition that causes progressive lung scarring. About 35 participants took either the study drug or a placebo pill for 12 weeks. The main goal was to check…
Phase: PHASE2 • Sponsor: GRI Bio Operations, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC